Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Saved in:
| Title: | Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. |
|---|---|
| Authors: | Hooper, Perry B.1 (AUTHOR), Farberg, Aaron S.2 (AUTHOR), Fitzgerald, Alison L.3 (AUTHOR), Siegel, Jennifer J.3 (AUTHOR), Rackley, Briana B.3 (AUTHOR), Prasai, Anesh3 (AUTHOR), Kurley, Sarah J.3 (AUTHOR), Goldberg, Matthew S.3 (AUTHOR), Litchman, Graham H.4 (AUTHOR) |
| Source: | Cancer Investigation. Nov2022, Vol. 40 Issue 10, p911-922. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
